Sturamustine

Sturamustine
Identifiers
IUPAC name N-(2-Chloroethyl)-N'-[(3β,17β)-3-hydroxyandrost-5-en-17-yl]-N-nitrosocarbamimidic acid
Synonyms	N-(2-Chloroethyl)-N'-(3-hydroxyandrost-5-en-17-yl)-N-nitrosourea
CAS Number	81912-55-2
ChemSpider	57260288
Chemical and physical data
Formula	C₂₂H₃₄ClN₃O₃
Molar mass	423.982 g/mol
3D model (Jmol)	Interactive image
SMILES C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2/N=C(/N(CCCl)N=O)\O)CC=C4[C@@]3(CC[C@@H](C4)O)C
InChI InChI=1S/C22H34ClN3O3/c1-21-9-7-15(27)13-14(21)3-4-16-17-5-6-19(22(17,2)10-8-18(16)21)24-20(28)26(25-29)12-11-23/h3,15-19,27H,4-13H2,1-2H3,(H,24,28)/t15-,16-,17-,18-,19-,21-,22-/m0/s1 Key:QSHCCJGNLACWQQ-UMWWKMARSA-N

Sturamustine, also known as dehydroepiandrosterone (DHEA) 17β-N-(2-chloroethyl)-N-nitrosourea, is a synthetic androstane steroid and a C17β nitrosourea conjugate of dehydroepiandrosterone (DHEA) that was developed as an alkylating antineoplastic agent (i.e., a chemotherapy drug) for the treatment of hormone-dependent tumors but was never marketed. It was synthesized in 1982.